Detalles de la búsqueda
1.
Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon.
Neurourol Urodyn
; 37(1): 440-448, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29095516
2.
Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.
Female Pelvic Med Reconstr Surg
; 24(3): 222-231, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28953076
3.
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings.
Curr Med Res Opin
; 34(10): 1771-1776, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29458265
4.
Patient experience with darifenacin - results of a short-term community-based survey in managing overactive bladder.
Curr Med Res Opin
; 27(2): 431-7, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21194391
Resultados
1 -
4
de 4
1
Próxima >
>>